Health Care [ 4/12 ] | Pharmaceuticals [ 9/75 ]
NASDAQ | Common Stock
Aardvark Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases.
Aardvark Therapeutics, Inc. was incorporated in 2017 and is headquartered in San Diego, California.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Mar 24, 26 | -0.81 Decreased by -86.21% | -0.83 Increased by +2.11% |
| Nov 13, 25 | -0.75 | -0.77 Increased by +2.60% |
| Aug 14, 25 | -0.66 | -0.68 Increased by +2.60% |
| May 14, 25 | -0.71 | -0.70 Decreased by -1.43% |
| Mar 31, 25 | -0.43 | -0.20 Decreased by -117.50% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Dec 31, 25 | 0.00 Decreased by N/A% | -17.60 M Decreased by -100.46% | Decreased by N/A% Decreased by N/A% |
| Sep 30, 25 | 0.00 Decreased by N/A% | -16.32 M Decreased by -290.15% | Decreased by N/A% Decreased by N/A% |
| Jun 30, 25 | 0.00 Decreased by N/A% | -14.37 M Decreased by -163.66% | Decreased by N/A% Decreased by N/A% |
| Mar 31, 25 | 0.00 Decreased by N/A% | -9.31 M Decreased by -327.46% | Decreased by N/A% Decreased by N/A% |
| Dec 31, 24 | 0.00 Decreased by N/A% | -8.78 M Decreased by -330.13% | Decreased by N/A% Decreased by N/A% |
| Sep 30, 24 | 0.00 Decreased by N/A% | -4.18 M Decreased by -98.29% | Decreased by N/A% Decreased by N/A% |
| Jun 30, 24 | 0.00 - | -5.45 M - | Decreased by N/A% - |
| Mar 31, 24 | 0.00 - | -2.18 M - | Decreased by N/A% - |